Vitreoretinal lymphoma: Changing trends in diagnosis and local treatment modalities at a single institution

Clinical Lymphoma, Myeloma and Leukemia

Volumn 12, Issue 6, 2012, Pages 412-417

  Turaka, Kiran ^a   Bryan, J Shepard ^a   De Souza, Stephen ^a   Gordon, Alan J ^a   Kwong, Henry M ^a   Ziemianski, Matthew C ^a   Reddy, Rahul ^a   Sell, Clive H ^a  

^a Associated Retina Consultants Ltd   (United States)

Author keywords

Central nervous system; External beam radiotherapy; Keratitis; Methotrexate; Non Hodgkin's lymphoma; Rituximab; Uveitis; Vitreoretinitis

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 6; METHOTREXATE; RITUXIMAB;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DISEASE ASSOCIATION; DRUG EFFECT; DRUG EFFICACY; DRUG RESPONSE; EXTERNAL BEAM RADIOTHERAPY; FEMALE; HUMAN; KERATITIS; LYMPHOMA; MALE; NEEDLE BIOPSY; PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA; PROGNOSIS; RADIATION DOSE; RETROSPECTIVE STUDY; SYMPTOM; TREATMENT OUTCOME; VITREORETINAL LYMPHOMA;

EID: 84869474316     PISSN: 21522650     EISSN: 21522669     Source Type: Journal    
DOI: 10.1016/j.clml.2012.07.006     Document Type: Article

References (25)

1. K. Peterson, K.B. Gordon, M.H. Heinemann The clinical spectrum of ocular lymphoma Cancer 72 1993 843 849
2. H.E. Verbraeken, M. Hanssens, H. Priem Ocular non-Hodgkin's lymphoma: a clinical study of nine cases Br J Ophthalmol 81 1997 31 36
3. J.T. Hong, J.B. Chae, J.Y. Lee Ocular involvement in patients with primary CNS lymphoma J Neurooncol 102 2011 139 145
4. J. Meunier, L. Lumbroso-Le Rouic, A. Vincent-Salomon Ophthalmologic and intraocular non-Hodgkin's lymphoma: a large single centre study of initial characteristics, natural history, and prognostic factors Hematol Oncol 22 2004 143 158
5. G.A. Levy-Clarke, D. Greenman, P.C. Sieving Ophthalmic manifestations, cytology, immunohistochemistry, and molecular analysis of intraocular metastatic T-cell lymphoma: report of a case and review of the literature Surv Ophthalmol 53 2008 285 295
6. K. Kimura, H. Goto The clinical findings and prognosis of 28 cases of intraocular lymphoma [in Japanese] Nihon Ganka Gakkai Zasshi 112 2008 674 678
7. G.S. Vosganian, S. Boisot, K.I. Hartmann Primary intraocular lymphoma: a review J Neurooncol 105 2011 127 134
8. R.B. Nussenblatt, C.C. Chan, W.H. Wilson International Central Nervous System and Ocular Lymphoma Workshop: recommendations for the future Ocul Immunol Inflamm 14 2006 139 144
9. C.C. Chan, J.L. Rubenstein, S.E. Coupland Primary vitreoretinal lymphoma: a report from an international primary Central Nervous System Lymphoma Collaborative Group symposium Oncologist 16 2011 1589 1599
10. K. Raparia, C.C. Chang, P. Chévez-Barrios Intraocular lymphoma: diagnostic approach and immunophenotypic findings in vitrectomy specimens Arch Pathol Lab Med 133 2009 1233 1237
11. H.N. Sen, B. Bodaghi, P.L. Hoang Primary intraocular lymphoma: diagnosis and differential diagnosis Ocul Immunol Inflamm 17 2009 133 141
12. R. Rajagopal, J.W. Harbour Diagnostic testing and treatment choices in primary vitreoretinal lymphoma Retina 31 2011 435 440
13. Y. Wang, D. Shen, V.M. Wang Molecular biomarkers for the diagnosis of primary vitreoretinal lymphoma Int J Mol Sci 12 2011 5684 5697
14. A. Berenbom, R.M. Davila, H.S. Lin Treatment outcomes for primary intraocular lymphoma: implications for external beam radiotherapy Eye (Lond) 21 2007 1198 1201
15. P.M. Hoffman, P. McKelvie, A.J. Hall Intraocular lymphoma: a series of 14 patients with clinicopathological features and treatment outcomes Eye (Lond) 17 2003 513 521
16. A. Stefanovic, J. Davis, T. Murray Treatment of isolated primary intraocular lymphoma with high-dose methotrexate-based chemotherapy and binocular radiation therapy: a single-institution experience Br J Haematol 151 2010 103 106
17. K. Taoka, G. Yamamoto, T. Kaburaki Treatment of primary intraocular lymphoma with rituximab, high dose methotrexate, procarbazine, and vincristine chemotherapy, reduced whole-brain radiotherapy, and local ocular therapy Br J Haematol 157 2012 252 254
18. J.R. Smith, J.T. Rosenbaum, D.J. Wilson Role of intravitreal methotrexate in the management of primary central nervous system lymphoma with ocular involvement Ophthalmology 109 2002 1709 1716
19. S. Frenkel, K. Hendler, T. Siegal Intravitreal methotrexate for treating vitreoretinal lymphoma: 10 years of experience Br J Ophthalmol 92 2008 383 388
20. M. Saleh, K. Nikolitch, T. Bourcier Repeated IL-10 measurement in aqueous humor and OCT imaging are valuable tools to monitor intraocular lymphoma treated with intravitreal injections of methotrexate Graefes Arch Clin Exp Ophthalmol 250 2012 761 764
21. H. Kawamura, N. Yasuda, M. Kakinoki Interleukin-10 and interleukin-6 in aqueous humor during treatment of vitreoretinal lymphoma with intravitreally injected methotrexate Ophthalmic Res 42 2009 172 174
22. A.S. Kitzmann, J.S. Pulido, B.G. Mohney Intraocular use of rituximab Eye (Lond) 21 2007 1524 1527
23. N. Ohguro, N. Hashida, Y. Tano Effect of intravitreous rituximab injections in patients with recurrent ocular lesions associated with central nervous system lymphoma Arch Ophthalmol 126 2008 1002 1003
24. E. Miserocchi, I. Pontikaki, G. Modorati Anti-CD 20 monoclonal antibody (rituximab) treatment for inflammatory ocular diseases Autoimmun Rev 11 2011 35 39
25. H.N. Sen, C.C. Chan, G. Byrnes Intravitreal methotrexate resistance in a patient with primary intraocular lymphoma Ocul Immunol Inflamm 16 2008 29 33